Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EBIT Growth

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 93.14298.54-62.910.46-30.07

What is the latest EBIT Growth ratio of NATCO PHARMA ?

The latest EBIT Growth ratio of NATCO PHARMA is 93.14 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202493.14
Mar2023298.54
Mar2022-62.91
Mar20210.46
Mar2020-30.07

How is EBIT Growth of NATCO PHARMA Trending?

Years EBIT Growth % Change
Mar2024 93.14
-68.80
Mar2023 298.54
Positive
Mar2022 -62.91
Negative
Mar2021 0.46
Positive
Mar2020 -30.07 -

Other Financial Ratios of NATCO PHARMA


Compare EBIT Growth ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹13,886.5 Cr -2.8% -4.5% -25.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,900.0 Cr -1.3% 4.7% 3.3% Stock Analytics
DIVIS LABORATORIES ₹148,474.0 Cr 1.9% 1.5% 41.9% Stock Analytics
CIPLA ₹118,166.0 Cr 3.4% 0.1% -3.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹105,849.0 Cr -4.8% 1.9% 20.3% Stock Analytics
DR REDDYS LABORATORIES ₹92,553.6 Cr -0.1% -1% -11.3% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-2.8%

-4.5%

-25.2%

SENSEX

-1.5%

1.1%

1.2%


You may also like the below Video Courses